The University of Kansas Cancer Center (KUCC)

Fairway, Kansas 66205

3 studies enrolling now · 9 studies all time

What they study most

Bladder Cancer, Breast Cancer, Colon Cancer, Digestive Cancer, Lung Cancer, NSCLC, NSCLC Stage IIIB, NSCLC Stage IV, NSCLC, Recurrent, Pancreas Cancer, Prostate Cancer, Triple-negative Breast Cancer

Studies at this site

• Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer — Recruiting now
• Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC — Recruiting now
• Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC — Recruiting now
• Intravenous (IV) Vitamin C With Chemotherapy for Cisplatin Ineligible Bladder Cancer Patients — Running, not enrolling
• CEND-1 in Combination with Neoadjuvant FOLFIRINOX with or Without Panitumumab — Running, not enrolling
• Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer — Status unconfirmed
• Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC) — Status unconfirmed
• Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy — Status unconfirmed
• Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients — Withdrawn before enrolling